Literature DB >> 19361520

Probing the Interactions of early polyketide intermediates with the Actinorhodin ACP from S. coelicolor A3(2).

Simon E Evans1, Christopher Williams, Christopher J Arthur, Eliza Płoskoń, Pakorn Wattana-amorn, Russell J Cox, John Crosby, Christine L Willis, Thomas J Simpson, Matthew P Crump.   

Abstract

Acyl carrier proteins (ACPs) are essential to both fatty acid synthase (FAS) and polyketide synthase (PKS) biosynthetic pathways, yet relatively little is known about how they function at a molecular level. Seven thiol ester and thiol ether derivatives of the actinorhodin (act) PKS ACP from Streptomyces coelicolor have been prepared and structurally characterised by NMR to gain insight into ACP-intermediate interactions. Holo ACP synthase has been used to prepare early-stage ACP intermediates of polyketide biosynthesis (holo ACP, acetyl ACP, and malonyl ACP) from the respective coenzyme A derivatives. A synthetic route to stabilised thiol ether ACPs was developed and applied to the preparation of stable 3-oxobutyl and 3,5-dioxohexyl ACP as diketide and triketide analogues. No interaction between the protein and the acyl phosphopantetheine moieties of acetyl, malonyl, or 3-oxobutyl ACP was detected. Analysis of (1)H-(15)N heteronuclear single quantum coherence and nuclear Overhauser enhancement spectroscopy spectra for the triketide ACP revealed exchange between a major ('Tri', 85%) and a minor protein conformer in which the polyketide interacts with the protein ('Tri(*)', 15%). Act ACP was also derivatised with butyryl, hexanoyl, and octanoyl groups. The corresponding NMR spectra showed large chemical shift perturbations centred on helices II and III, indicative of acyl chain binding and significant structural rearrangement. Unexpectedly, butyryl act ACP showed almost identical backbone (1)H-(15)N chemical shifts to Tri(*), suggesting comparable structural changes that might provide insight into the structurally uncharacterised polyketide bound form. Furthermore, butyryl ACP itself underwent slow conformational exchange with a second minor conformer (But(*)) with almost identical backbone chemical shifts to octanoyl act ACP. High-resolution NMR structures of these acylated forms revealed that act ACP was able to undergo dramatic conformational changes that exceed those seen in FAS ACPs. When compared to E. coli FAS ACP, the substrate binding pocket of the act PKS ACP has three specific amino acid substitutions (Thr39/Leu45, Ala68/Leu74, and Leu42/Thr48) that alter the size, shape, and location of this cavity. These conformational changes may play a role in protein-protein recognition and assist the binding of bulky polyketide intermediates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361520     DOI: 10.1016/j.jmb.2009.03.072

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Binding and "pKa" modulation of a polycyclic substrate analogue in a type II polyketide acyl carrier protein.

Authors:  Robert W Haushalter; Fabian V Filipp; Kwang-Seuk Ko; Ricky Yu; Stanley J Opella; Michael D Burkart
Journal:  ACS Chem Biol       Date:  2011-02-22       Impact factor: 5.100

2.  Probing the interactions of an acyl carrier protein domain from the 6-deoxyerythronolide B synthase.

Authors:  Louise K Charkoudian; Corey W Liu; Stefania Capone; Shiven Kapur; David E Cane; Antonio Togni; Dieter Seebach; Chaitan Khosla
Journal:  Protein Sci       Date:  2011-07       Impact factor: 6.725

3.  A nuclear magnetic resonance method for probing molecular influences of substrate loading in nonribosomal peptide synthetase carrier proteins.

Authors:  Andrew C Goodrich; Dominique P Frueh
Journal:  Biochemistry       Date:  2015-01-29       Impact factor: 3.162

4.  Solution structure of 4'-phosphopantetheine - GmACP3 from Geobacter metallireducens: a specialized acyl carrier protein with atypical structural features and a putative role in lipopolysaccharide biosynthesis.

Authors:  Theresa A Ramelot; Matthew J Smola; Hsiau-Wei Lee; Colleen Ciccosanti; Keith Hamilton; Thomas B Acton; Rong Xiao; John K Everett; James H Prestegard; Gaetano T Montelione; Michael A Kennedy
Journal:  Biochemistry       Date:  2011-02-14       Impact factor: 3.162

5.  Characterization of molecular interactions between ACP and halogenase domains in the Curacin A polyketide synthase.

Authors:  Alena Busche; Daniel Gottstein; Christopher Hein; Nina Ripin; Irina Pader; Peter Tufar; Eli B Eisman; Liangcai Gu; Christopher T Walsh; David H Sherman; Frank Löhr; Peter Güntert; Volker Dötsch
Journal:  ACS Chem Biol       Date:  2011-12-15       Impact factor: 5.100

6.  Interrogation of global active site occupancy of a fungal iterative polyketide synthase reveals strategies for maintaining biosynthetic fidelity.

Authors:  Anna L Vagstad; Stefanie B Bumpus; Katherine Belecki; Neil L Kelleher; Craig A Townsend
Journal:  J Am Chem Soc       Date:  2012-04-09       Impact factor: 15.419

7.  Structural and biochemical characterization of ZhuI aromatase/cyclase from the R1128 polyketide pathway.

Authors:  Brian D Ames; Ming-Yue Lee; Colleen Moody; Wenjun Zhang; Yi Tang; Shiou-Chuan Tsai
Journal:  Biochemistry       Date:  2011-09-08       Impact factor: 3.162

Review 8.  Structural analysis of protein-protein interactions in type I polyketide synthases.

Authors:  Wei Xu; Kangjian Qiao; Yi Tang
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-12-19       Impact factor: 8.250

9.  Understanding Programming of Fungal Iterative Polyketide Synthases: The Biochemical Basis for Regioselectivity by the Methyltransferase Domain in the Lovastatin Megasynthase.

Authors:  Ralph A Cacho; Justin Thuss; Wei Xu; Randy Sanichar; Zhizeng Gao; Allison Nguyen; John C Vederas; Yi Tang
Journal:  J Am Chem Soc       Date:  2015-12-10       Impact factor: 15.419

Review 10.  Type II fatty acid and polyketide synthases: deciphering protein-protein and protein-substrate interactions.

Authors:  Aochiu Chen; Rebecca N Re; Michael D Burkart
Journal:  Nat Prod Rep       Date:  2018-10-17       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.